Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Frontiers in Immunology|October 24, 2022
GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBCHuaying Xie, Tingting Yan, Xinxin Lu, et al.Cancer Medicine|October 31, 2019
Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: A prospective randomized controlled trialYan Liu, Jiaxin Sun, Tong Wu, et al.Oncotargets and Therapy|March 3, 2018
Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant settingZiping Wu, Shuguang Xu, Liheng Zhou, et al.Journal of Experimental & Clinical Cancer Research : CR|June 24, 2021
LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replicationXiaonan Sheng, Huijuan Dai, Yueyao Du, et al.Frontiers in Cell and Developmental Biology|October 1, 2021
HIF1α Regulates IL17 Signaling Pathway Influencing Sensitivity of Taxane-Based Chemotherapy for Breast CancerHuijuan Dai, Xiaonan Sheng, Yaohui Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2022
Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II StudyWenjin Yin, Yaohui Wang, Ziping Wu, et al.Frontiers in Oncology|May 20, 2020
Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target TherapyShan Zhang, Yaohui Wang, Yan Wang, et al.Pageof 4